Volume 7, Number 7—June 2001
International Conference on Emerging Infectious Diseases 2000
Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?
- Willems RJL, Mooi FR. From whole cell to acellular pertussis vaccines. Reviews in Medical Microbiology. 1996;7:13–21.
- Halparin SA. Developing better paediatric vaccines. The case of pertussis vaccine. BioDrugs. 1999;12:175–91.
- Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol. 1999;20:120–3.
- Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999;28:S112–7.
- Andrews R, Herceq A, Roberts C. Pertussis notifications in Australia. Commun Dis Intell. 1997;21:145–8.
- DeSerres G, Boulianne N, Douville-Fradet M, Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep. 1995;15:45–8.
- De Melker HE, Conyn-van Spaendock MAE, Rümke HC, van Wijngaarden JK, Mooi FR, Schellekens JFP. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole cell vaccine. Emerg Infect Dis. 1997;3:175–8.
- Mooi FR, van Oirschot H, Heuvelman K, van der Heide HGJ, Gaastra W, Willems RJL. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998;66:670–5.
- Van der Zee A, Vernooij S, Peeters M, van Embden JDA, Mooi FR. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 1996;142:3479–85.
- Van Loo IHM, van der Heide HGJ, Nagelkerke NJD, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetella pertussis in the years 1949-1996 in a highly vaccinated population. J Infect Dis. 1999;79:915–23.
- Nei M, Tajima F. DNA polymorphism detectable by restriction endonucleases. Genetics. 1981;97:145–63.
- Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 1998;16:1901–6.
- Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16:907–16.
- De Magistris MTA, DiTommaso A, Domenighini M, Censini S, Tagliabue AJR, Oksenberg L, Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. Proc Natl Acad Sci U S A. 1992;89:2990–4.
- Everest P, Li L, Douce G, Charles I, De Azavedo J, Chatfield S, Role of Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cell. Microbiology. 1996;142:3261–8.
- Streisinger G, Owen JE. Mechanisms of spontaneous and induced frameshift mutations in bacteriophage T4. Genetics. 1984;109:633–59.
- Mooi FR. Qiushui He, van Oirschot H, Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun. 1999;67:3133–4.
- Cassiday P, Sanden G, Heuvelman K, Mooi FR, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis. 2000;12:1402–8.
- Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HGL, Heuvelman K, Stefanelli P, Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology. 1999;45:2069–75.
- Ochman H, Wilson AC. Evolution in bacteria: evidence for a universal substitution rate in cellular genomes. J Mol Evol. 1987;26:74–86.
Page created: April 27, 2012
Page updated: April 27, 2012
Page reviewed: April 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.